Overall Status

Active, not recruiting (2)

Recruiting (1)

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

University Hospital Southampton NHS Foundation Trust (1)

Collaborator

Cancer Research UK (1)

Celldex Therapeutics (1)

Oxford University Hospitals NHS Trust (1)

The Christie NHS Foundation Trust (1)

University Hospital Plymouth NHS Trust (1)

Intervention

varlilumab (3)

atezolizumab (1)

biopsy (1)

biospecimen collection (1)

cobimetinib (1)

computed tomography (1)

magnetic resonance imaging (1)

nivolumab (1)

Study Documents

Intervention Type

drug (3)

biological (2)

procedure (1)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

varlilumab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B Cell Lymphoma Trial in United Kingdom (Varlilumab)

Active, not recruiting

B Cell Lymphoma

Varlilumab

Manchester, United Kingdom
+3 more

Oct 26, 2022

Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

Recruiting

Metastatic Distal Bile Duct Adenocarcinoma
+9 more

Atezolizumab
+6 more

Phoenix, Arizona
+28 more

Dec 31, 2022

ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

Active, not recruiting

ALK-Positive Large B-Cell Lymphoma
+34 more

Nivolumab
Varlilumab

Phoenix, Arizona
+32 more

Jan 3, 2023